ClinicalTrials.gg
Drug

incobotulinumtoxinA clinical trials

Also written NT 201.

A product of Botulinum toxin type A; its studies count on that page too.

studies test it
19
open now
1
in phase 3
9
first study started
2007

How each study uses incobotulinumtoxinA is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the incobotulinumtoxinA studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Dec 1991 · BOTOX COSMETIC · BLA 103000 (FDA, Drugs@FDA; as botulinum toxin type A)
European Union
27 Sept 2019 · Nuceiva · EMEA/H/C/004587 (EMA; as botulinum toxin type A)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

IncobotulinumtoxinA
11
Xeomin
7
Xeomin/Bocouture
4
Xeomin Cosmetic
4
Xeomeen
4

Development codes

NT 201
13

Studies by the year they started

19 studies that test it; most in 2007 (2)

Studies that test incobotulinumtoxinA, by start year
YearStudies
20072
20082
20091
20101
20121
20141
20151
20192
20202
20211
20221
20231
20241
20252

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
8
Phase 3
9
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 4

Merz Pharmaceuticals GmbH (8) · Merz North America, Inc. (4) · Merz Aesthetics GmbH (3) · Buddhist Tzu Chi General Hospital (1) · University of Malaya (1) · University of Miami (1) · Sir Run Run Shaw Hospital (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test incobotulinumtoxinA.

Studies

Open first, then newest update. How each study uses incobotulinumtoxinA is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Given beside what is tested · 1 — incobotulinumtoxinA is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 21, 2026.

Codes

What other systems call incobotulinumtoxinA · ClinicalTrials.gg INT005533

  • MeSH (NLM) C545476incobotulinumtoxinAOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.